查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1583823

全球 HbA1c 測試市場研究報告 - 2024 年至 2032 年行業分析、規模、佔有率、成長、趨勢和預測

Global HbA1c Testing Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032
出版日期: | 出版商: Value Market Research | 英文 170 Pages | 商品交期: 最快1-2個工作天內

價格

預計全球 HbA1c 檢測市場需求將從 2023 年的 27.7 億美元增至 2032 年近 61.2 億美元，2024-2032 年研究期間複合年成長率為 9.22%。

HbA1c 測試透過評估血液樣本中的糖化血紅蛋白來測量過去兩到三個月的平均血糖值。此測試通常用於監測糖尿病管理，反映長期血糖控制而不是日常波動，從而更全面地了解一個人的血糖水平。 HbA1c 結果可幫助醫療保健提供者調整治療方法並評估糖尿病風險，高於特定閾值的水平表示血糖控制不佳。常規 HbA1c 檢測對於糖尿病管理至關重要，可引導患者達到目標血糖水平、降低併發症風險並促進整體代謝健康。

市場動態

由於糖尿病盛行率不斷上升以及有效血糖監測的需求，HbA1c 測試市場正在不斷成長。 HbA1c 測試為長期血糖控制提供了寶貴的見解，使其對於糖尿病管理和監測至關重要。隨著全球糖尿病發病率的上升，醫療保健提供者正在強調常規 HbA1c 檢測，以預防併發症並改善患者治療結果。現場檢測和家庭檢測套件的技術進步進一步推動了 HbA1c 檢測市場，為患者提供了更快、更方便的檢測選擇。專注於糖尿病意識和預防的政府醫療保健計劃和措施也促進了對 HbA1c 檢測的需求。隨著個人優先考慮定期健康監測，不斷增強的健康意識和預防性醫療保健實踐繼續推動 HbA1c 檢測市場。然而，低度開發地區缺乏意識和高昂的檢測成本可能會挑戰未來幾年 HbA1c 檢測市場的成長。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具還對全球 HbA1c 測試市場的每個細分市場進行包容性評估。 HbA1c 測試產業的成長和趨勢為本研究提供了整體方法。

市場區隔

HbA1c 測試市場報告的這一部分提供了國家和區域級別細分市場的詳細資料，從而幫助策略師確定相應產品或服務的目標人群以及即將到來的機會。

按類型

  • 實驗室測試
  • 即時護理 (POC) 測試

依技術

  • 免疫測定
  • 色譜法
  • 酵素法檢測
  • 硼酸鹽親和層析法
  • 高效液相層析
  • 其他

按最終用途

  • 醫院和診所
  • 診斷實驗室
  • 家庭護理設置
  • 其他
  • 區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲 HbA1c 測試市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。 HbA1c 測試市場的主要參與者包括 Abbott Laboratories、Arkray Inc.、Bio-Rad Laboratories Inc.、Ceragem Medisys Inc.、Danaher Corporation、EKF Diagnostics、F. Hoffmann-La Roche Ltd.、Human、Menarini Diagnostics SRL、PTS診斷診斷、Randox Laboratories Ltd.、Sakae Co. Ltd.、Sekisui Medical Co. Ltd.、Siemens Healthineers AG、Trinity Biotech Plc.本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

目錄

第1章：前言

  • 報告說明
    • 客觀的
    • 目標受眾
    • 獨特的銷售主張 (USP) 和產品
  • 研究範圍
  • 研究方法
    • 市場研究過程
    • 市場研究方法論

第 2 章：執行摘要

  • 市場亮點
  • 全球市場概況

第 3 章：HBA1C 測驗 - 產業分析

  • 簡介 - 市場動態
  • 市場促進因素
  • 市場限制
  • 機會
  • 產業動態
  • 波特五力分析
  • 市場吸引力分析
    • 按類型分類的市場吸引力分析
    • 按技術分類的市場吸引力分析
    • 按最終用途分類的市場吸引力分析
    • 市場吸引力分析：按地區

第 4 章：價值鏈分析

  • 價值鏈分析
  • 原料分析
    • 原料清單
    • 原料廠商清單
    • 主要原物料價格走勢
  • 潛在買家名單
  • 行銷管道
    • 直效行銷
    • 間接行銷
    • 行銷通路發展趨勢

第 5 章：全球 HBA1C 測試市場分析：按類型

  • 按類型概述
  • 按類型分類的歷史和預測資料分析
  • 實驗室測試
  • 即時護理 (POC) 測試

第 6 章：全球 HBA1C 測試市場分析：依技術分類

  • 依技術概述
  • 按技術進行歷史和預測數據分析
  • 免疫測定
  • 色譜法
  • 酵素法檢測
  • 硼酸鹽親和層析法
  • 高效液相層析
  • 其他

第 7 章：全球 HBA1C 測試市場分析：依最終用途分類

  • 按最終用途分類的概述
  • 按最終用途分類的歷史和預測資料分析
  • 醫院和診所
  • 診斷實驗室
  • 家庭護理設置
  • 其他

第 8 章：全球 HBA1C 測試市場分析：按地理位置

  • 區域展望
  • 介紹
  • 北美銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 北美按細分市場銷售分析
    • 北美按國家銷售分析
    • 美國銷售分析
    • 加拿大銷售分析
    • 墨西哥銷售分析
  • 歐洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 歐洲按細分市場銷售分析
    • 歐洲按國家銷售分析
    • 英國銷售分析
    • 法國銷售分析
    • 德國銷售分析
    • 義大利銷售分析
    • 俄羅斯銷售分析
    • 歐洲其他地區銷售分析
  • 亞太地區銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 亞太地區按細分市場銷售分析
    • 亞太地區按國家銷售分析
    • 中國銷售分析
    • 印度銷售分析
    • 日本銷售分析
    • 韓國銷售分析
    • 澳洲銷售分析
    • 東南亞銷售分析
    • 亞太地區其他地區銷售分析
  • 拉丁美洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 拉丁美洲按細分市場銷售分析
    • 拉丁美洲按國家銷售分析
    • 巴西銷售分析
    • 阿根廷銷售分析
    • 秘魯銷售分析
    • 智利銷售分析
    • 拉丁美洲其他地區銷售分析
  • 中東和非洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 中東和非洲按細分市場銷售分析
    • 中東和非洲按國家銷售分析
    • 沙烏地阿拉伯銷售分析
    • 阿拉伯聯合大公國銷售分析
    • 以色列銷售分析
    • 南非銷售分析
    • 中東其他地區和非洲銷售分析

第 9 章：HBA1C 測試公司的競爭格局

  • HbA1c 檢測市場競爭
  • 夥伴關係/協作/協議
  • 併購
  • 新產品發布
  • 其他發展

第 10 章：公司簡介

  • 頂級公司市佔率分析
  • 市場集中度
  • Abbott Laboratories
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Arkray Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Bio-Rad Laboratories Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Ceragem Medisys Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Danaher Corporation
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • EKF Diagnostics
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • F. Hoffmann-La Roche Ltd.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Human
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Menarini Diagnostics SRL
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • PTS Diagnostics
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Randox Laboratories Ltd.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Sakae Co. Ltd.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Sekisui Medical Co. Ltd.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Siemens Healthineers AG
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Trinity Biotech Plc
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態

註 - 在公司概況中，財務詳細資訊和最新發展視情況而定，或對私人公司而言可能不包括在內

Product Code: VMR11210079

The global demand for HbA1c Testing Market is presumed to reach the market size of nearly USD 6.12 Billion by 2032 from USD 2.77 Billion in 2023 with a CAGR of 9.22% under the study period 2024-2032.

HbA1c testing measures the average blood glucose levels over the past two to three months by assessing the glycated hemoglobin in blood samples. Often used to monitor diabetes management, this test reflects long-term glucose control rather than daily fluctuations, providing a more comprehensive view of a person's blood sugar levels. HbA1c results help healthcare providers adjust treatments and evaluate diabetes risks, with levels above specific thresholds indicating poor glucose control. Routine HbA1c testing is essential for diabetes management, guiding patients in achieving target blood sugar levels, reducing risks of complications, and promoting overall metabolic health.

Market Dynamics

The HbA1c testing market is witnessing growth due to the rising prevalence of diabetes and the need for effective glucose monitoring. HbA1c tests provide valuable insights into long-term blood sugar control, making them essential for diabetes management and monitoring. As diabetes rates increase globally, healthcare providers are emphasizing routine HbA1c testing to prevent complications and improve patient outcomes. Technological advancements in point-of-care testing and at-home testing kits have further propelled the HbA1c testing market, enabling faster and more convenient testing options for patients. Government healthcare programs and initiatives focused on diabetes awareness and prevention have also contributed to the demand for HbA1c testing. Growing health consciousness and preventive healthcare practices continue to drive the HbA1c testing market as individuals prioritize regular health monitoring. However, the lack of awareness in underdeveloped regions and high testing costs may challenge the HbA1c Testing market growth in the coming years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of HbA1c Testing. The growth and trends of HbA1c Testing industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the HbA1c Testing market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

  • Laboratory-Based Testing
  • Point-Of-Care (POC) Testing

By Technology

  • Immunoassays
  • Chromatography
  • Enzymatic Assays
  • Boronate Affinity Chromatography
  • High-Performance Liquid Chromatography
  • Other

By End-use

  • Hospitals & Clinics
  • Diagnostic Laboratories
  • Homecare Settings
  • Other
  • Regional Analysis

This section covers the regional outlook, which accentuates current and future demand for the HbA1c Testing market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the HbA1c Testing market include Abbott Laboratories, Arkray Inc., Bio-Rad Laboratories Inc., Ceragem Medisys Inc., Danaher Corporation, EKF Diagnostics, F. Hoffmann-La Roche Ltd., Human, Menarini Diagnostics S.R.L., PTS Diagnostics, Randox Laboratories Ltd., Sakae Co. Ltd., Sekisui Medical Co. Ltd., Siemens Healthineers AG, Trinity Biotech Plc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. HBA1C TESTING - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Type
    • 3.7.2 Market Attractiveness Analysis By Technology
    • 3.7.3 Market Attractiveness Analysis By End-use
    • 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL HBA1C TESTING MARKET ANALYSIS BY TYPE

  • 5.1. Overview By Type
  • 5.2. Historical and Forecast Data Analysis By Type
  • 5.3. Laboratory-Based Testing Historic and Forecast Sales By Regions
  • 5.4. Point-Of-Care (POC) Testing Historic and Forecast Sales By Regions

6. GLOBAL HBA1C TESTING MARKET ANALYSIS BY TECHNOLOGY

  • 6.1. Overview By Technology
  • 6.2. Historical and Forecast Data Analysis By Technology
  • 6.3. Immunoassays Historic and Forecast Sales By Regions
  • 6.4. Chromatography Historic and Forecast Sales By Regions
  • 6.5. Enzymatic Assays Historic and Forecast Sales By Regions
  • 6.6. Boronate Affinity Chromatography Historic and Forecast Sales By Regions
  • 6.7. High-Performance Liquid Chromatography Historic and Forecast Sales By Regions
  • 6.8. Other Historic and Forecast Sales By Regions

7. GLOBAL HBA1C TESTING MARKET ANALYSIS BY END-USE

  • 7.1. Overview By End-use
  • 7.2. Historical and Forecast Data Analysis By End-use
  • 7.3. Hospitals & Clinics Historic and Forecast Sales By Regions
  • 7.4. Diagnostic Laboratories Historic and Forecast Sales By Regions
  • 7.5. Homecare Settings Historic and Forecast Sales By Regions
  • 7.6. Other Historic and Forecast Sales By Regions

8. GLOBAL HBA1C TESTING MARKET ANALYSIS BY GEOGRAPHY

  • 8.1. Regional Outlook
  • 8.2. Introduction
  • 8.3. North America Sales Analysis
    • 8.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.3.2 North America By Segment Sales Analysis
    • 8.3.3 North America By Country Sales Analysis
    • 8.3.4 United States Sales Analysis
    • 8.3.5 Canada Sales Analysis
    • 8.3.6 Mexico Sales Analysis
  • 8.4. Europe Sales Analysis
    • 8.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.4.2 Europe By Segment Sales Analysis
    • 8.4.3 Europe By Country Sales Analysis
    • 8.4.4 United Kingdom Sales Analysis
    • 8.4.5 France Sales Analysis
    • 8.4.6 Germany Sales Analysis
    • 8.4.7 Italy Sales Analysis
    • 8.4.8 Russia Sales Analysis
    • 8.4.9 Rest Of Europe Sales Analysis
  • 8.5. Asia Pacific Sales Analysis
    • 8.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.5.2 Asia Pacific By Segment Sales Analysis
    • 8.5.3 Asia Pacific By Country Sales Analysis
    • 8.5.4 China Sales Analysis
    • 8.5.5 India Sales Analysis
    • 8.5.6 Japan Sales Analysis
    • 8.5.7 South Korea Sales Analysis
    • 8.5.8 Australia Sales Analysis
    • 8.5.9 South East Asia Sales Analysis
    • 8.5.10 Rest Of Asia Pacific Sales Analysis
  • 8.6. Latin America Sales Analysis
    • 8.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.6.2 Latin America By Segment Sales Analysis
    • 8.6.3 Latin America By Country Sales Analysis
    • 8.6.4 Brazil Sales Analysis
    • 8.6.5 Argentina Sales Analysis
    • 8.6.6 Peru Sales Analysis
    • 8.6.7 Chile Sales Analysis
    • 8.6.8 Rest of Latin America Sales Analysis
  • 8.7. Middle East & Africa Sales Analysis
    • 8.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.7.2 Middle East & Africa By Segment Sales Analysis
    • 8.7.3 Middle East & Africa By Country Sales Analysis
    • 8.7.4 Saudi Arabia Sales Analysis
    • 8.7.5 UAE Sales Analysis
    • 8.7.6 Israel Sales Analysis
    • 8.7.7 South Africa Sales Analysis
    • 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE HBA1C TESTING COMPANIES

  • 9.1. HbA1c Testing Market Competition
  • 9.2. Partnership/Collaboration/Agreement
  • 9.3. Merger And Acquisitions
  • 9.4. New Product Launch
  • 9.5. Other Developments

10. COMPANY PROFILES OF HBA1C TESTING INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Market Concentration Rate
  • 10.3. Abbott Laboratories
    • 10.3.1 Company Overview
    • 10.3.2 Company Revenue
    • 10.3.3 Products
    • 10.3.4 Recent Developments
  • 10.4. Arkray Inc.
    • 10.4.1 Company Overview
    • 10.4.2 Company Revenue
    • 10.4.3 Products
    • 10.4.4 Recent Developments
  • 10.5. Bio-Rad Laboratories Inc.
    • 10.5.1 Company Overview
    • 10.5.2 Company Revenue
    • 10.5.3 Products
    • 10.5.4 Recent Developments
  • 10.6. Ceragem Medisys Inc.
    • 10.6.1 Company Overview
    • 10.6.2 Company Revenue
    • 10.6.3 Products
    • 10.6.4 Recent Developments
  • 10.7. Danaher Corporation
    • 10.7.1 Company Overview
    • 10.7.2 Company Revenue
    • 10.7.3 Products
    • 10.7.4 Recent Developments
  • 10.8. EKF Diagnostics
    • 10.8.1 Company Overview
    • 10.8.2 Company Revenue
    • 10.8.3 Products
    • 10.8.4 Recent Developments
  • 10.9. F. Hoffmann-La Roche Ltd.
    • 10.9.1 Company Overview
    • 10.9.2 Company Revenue
    • 10.9.3 Products
    • 10.9.4 Recent Developments
  • 10.10. Human
    • 10.10.1 Company Overview
    • 10.10.2 Company Revenue
    • 10.10.3 Products
    • 10.10.4 Recent Developments
  • 10.11. Menarini Diagnostics S.R.L.
    • 10.11.1 Company Overview
    • 10.11.2 Company Revenue
    • 10.11.3 Products
    • 10.11.4 Recent Developments
  • 10.12. PTS Diagnostics
    • 10.12.1 Company Overview
    • 10.12.2 Company Revenue
    • 10.12.3 Products
    • 10.12.4 Recent Developments
  • 10.13. Randox Laboratories Ltd.
    • 10.13.1 Company Overview
    • 10.13.2 Company Revenue
    • 10.13.3 Products
    • 10.13.4 Recent Developments
  • 10.14. Sakae Co. Ltd.
    • 10.14.1 Company Overview
    • 10.14.2 Company Revenue
    • 10.14.3 Products
    • 10.14.4 Recent Developments
  • 10.15. Sekisui Medical Co. Ltd.
    • 10.15.1 Company Overview
    • 10.15.2 Company Revenue
    • 10.15.3 Products
    • 10.15.4 Recent Developments
  • 10.16. Siemens Healthineers AG
    • 10.16.1 Company Overview
    • 10.16.2 Company Revenue
    • 10.16.3 Products
    • 10.16.4 Recent Developments
  • 10.17. Trinity Biotech Plc
    • 10.17.1 Company Overview
    • 10.17.2 Company Revenue
    • 10.17.3 Products
    • 10.17.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Type (USD MN)
  • Laboratory-Based Testing Market Sales By Geography (USD MN)
  • Point-Of-Care (POC) Testing Market Sales By Geography (USD MN)
  • Analysis By Technology (USD MN)
  • Immunoassays Market Sales By Geography (USD MN)
  • Chromatography Market Sales By Geography (USD MN)
  • Enzymatic Assays Market Sales By Geography (USD MN)
  • Boronate Affinity Chromatography Market Sales By Geography (USD MN)
  • High-Performance Liquid Chromatography Market Sales By Geography (USD MN)
  • Other Market Sales By Geography (USD MN)
  • Analysis By End-use (USD MN)
  • Hospitals & Clinics Market Sales By Geography (USD MN)
  • Diagnostic Laboratories Market Sales By Geography (USD MN)
  • Homecare Settings Market Sales By Geography (USD MN)
  • Other Market Sales By Geography (USD MN)
  • Global HbA1c Testing Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of HbA1c Testing Report
  • Market Research Process
  • Market Research Methodology
  • Global HbA1c Testing Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Type
  • Market Attractiveness Analysis By Technology
  • Market Attractiveness Analysis By End-use
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Type (USD MN)
  • Laboratory-Based Testing Market Sales By Geography (USD MN)
  • Point-Of-Care (POC) Testing Market Sales By Geography (USD MN)
  • Global Market Analysis By Technology (USD MN)
  • Immunoassays Market Sales By Geography (USD MN)
  • Chromatography Market Sales By Geography (USD MN)
  • Enzymatic Assays Market Sales By Geography (USD MN)
  • Boronate Affinity Chromatography Market Sales By Geography (USD MN)
  • High-Performance Liquid Chromatography Market Sales By Geography (USD MN)
  • Other Market Sales By Geography (USD MN)
  • Global Market Analysis By End-use (USD MN)
  • Hospitals & Clinics Market Sales By Geography (USD MN)
  • Diagnostic Laboratories Market Sales By Geography (USD MN)
  • Homecare Settings Market Sales By Geography (USD MN)
  • Other Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.